Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.42 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.42 |
| ▸ | NNMT | P40261 | 4/20 | 0.42 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.42 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | AHR | P35869 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | PARP1 | P09874 | 3/20 | 0.39 |
| ▸ | CDC7 | O00311 | 1/20 | 0.38 |
| ▸ | CCNC | P24863 | 1/20 | 0.37 |
| ▸ | CDK8 | P49336 | 1/20 | 0.37 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5796678 | 0.98 | SIRT3 (0.44) | SIRT3TDP1KDM4EL3MBTL1MKNK1 | |
| SCHEMBL5169967 | 0.82 | NOS3 (0.52) | SIRT3TDP1KDM4EL3MBTL1MKNK1 | |
| SCHEMBL5169958 | 0.82 | SIRT3 (0.44) | SIRT3TDP1KDM4EL3MBTL1MKNK1 | |
| SCHEMBL19439221 | 0.82 | SIRT3 (0.44) | SIRT3TDP1KDM4EL3MBTL1MKNK2 | |
| SCHEMBL9002808 | 0.82 | SIRT3 (0.44) | SIRT3TDP1KDM4EL3MBTL1MKNK1 | |
| SCHEMBL6628065 | 0.81 | SMN1; SMN2 (0.45) | KDM4EP2RX7RAB9ASMN1; SMN2ALDH1A1 | |
| SCHEMBL353106 | 0.81 | KDM4E (0.47) | TDP1KDM4EL3MBTL1MAPTRAB9A | |
| SCHEMBL16447580 | 0.80 | SIRT3 (0.43) | SIRT3TDP1KDM4EL3MBTL1MKNK1 | |
| SCHEMBL15991433 | 0.80 | SIRT3 (0.43) | SIRT3TDP1KDM4EL3MBTL1NNMT | |
| SCHEMBL17195496 | 0.80 | MKNK1 (0.44) | SIRT3TDP1KDM4EL3MBTL1MKNK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 119 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111868037-A | Fused cyclic urea derivatives as CRHR2 antagonists | 拉夸里亚创药株式会社 | 2020-10-30 | — | — | CN | claimed |
| CN-101065358-B | 3-arylamino pyridine derivatives | MERCK SERONO SA | 2015-03-11 | — | — | CN | claimed |
| CN-103408486-A | Preparation method of 4-pyridinemethanol | UNIV GUILIN TECH GUT | 2013-11-27 | — | — | CN | claimed |
| EP-1802579-B1 | Derivatives of 3-arylaminopyridine | MERCK SERONO SA (CH) | 2013-11-20 | — | — | EP | claimed |
| CN-103249721-A | Arylamine Derivatives as TTX-S Blockers | RAQUALIA PHARMA INC | 2013-08-14 | — | — | CN | claimed |
| CN-101065358-A | 3-arylamino pyridine derivatives | APPLIED RESEARCH SYSTEMS (AN) | 2007-10-31 | — | — | CN | claimed |
| WO-1998033786-A9 | ACCELERATED CATALYSIS OF OLEFINIC EPOXIDATIONS | — | 1998-12-30 | — | — | WO | claimed |
| WO-1998033786-A1 | ACCELERATED CATALYSIS OF OLEFINIC EPOXIDATIONS | THE SCRIPPS RESEARCH INSTITUTE (US) | 1998-08-06 | — | — | WO | claimed |
| US-20250129044-A1 | PYRIDINYL DERIVATIVES AS SODIUM CHANNEL ACTIVATORS | XENON PHARMACEUTICALS INC. (CA) | 2025-04-24 | — | — | US | disclosed |
| CN-113307772-B | Human plasma kallikrein inhibitors | 拜奥克里斯特制药公司 | 2024-06-28 | — | — | CN | disclosed |
| CN-118103369-A | Pyridolactam derivatives, preparation method and application thereof | 浙江海正药业股份有限公司 | 2024-05-28 | — | — | CN | disclosed |
| CN-112312905-B | Tetrazole-containing inhibitors of apoptosis signal-regulating kinase 1 and methods of use thereof | 英安塔制药有限公司 | 2024-03-15 | — | — | CN | disclosed |
| CN-117355303-A | Compounds and their use for the treatment of neurodegenerative, degenerative and metabolic disorders | 佛罗里达大学研究基金会公司 | 2024-01-05 | — | — | CN | disclosed |
| CN-117105933-A | Substituted 6-azabenzimidazole compounds having HPK1 inhibitory activity | 吉利德科学公司 | 2023-11-24 | — | — | CN | disclosed |
| CN-1390215-A | Tyrosine kinase inhibitors | MERCK & CO INC (US) | 2003-01-08 | — | — | CN | disclosed |
| CN-1320652-A | Salt of polyacylimino-amic acid and polyacylimine film formed therefrom | PLEX TECHNOLOGIES CORP (US) | 2001-11-07 | — | — | CN | disclosed |
| WO-1998033786-A9 | ACCELERATED CATALYSIS OF OLEFINIC EPOXIDATIONS | — | 1998-12-30 | — | — | WO | disclosed |
| WO-1998033786-A1 | ACCELERATED CATALYSIS OF OLEFINIC EPOXIDATIONS | THE SCRIPPS RESEARCH INSTITUTE (US) | 1998-08-06 | — | — | WO | disclosed |
| CN-1184813-A | Pyridine derivatives, process for preparing the same, and intermediate therefor | TANABE SEIYAKU CO (JP) | 1998-06-17 | — | — | CN | disclosed |
| US-4693726-A | Process for dyeing or printing cellulose fibers or cellulose blend fibers with pyridinium-triazine reactive dye, axable without alkali | HOECHST AKTIENGESELLSCHAFT (DE) | 1987-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250129044-A1 | PYRIDINYL DERIVATIVES AS SODIUM CHANNEL ACTIVATORS | SCN1B, SCN1A, SCN2B | SIRT3 760/4885TDP1 1890/4885KDM4E 1340/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.